Lipocine Inc. (LPCN) stock
LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.60−0.06 (-3.61%)
Close on Nov 17, 2026Market cap $13.19MP/E –Yield –
Lipocine EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Lipocine's EV/EBITDA was 3.9× on Jan 31, 2023.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 3.9× | +3.6 |
| 2022 | Dec 30, 2022 | 0.3× | – |
See a number that looks wrong?